10:33 AM EST, 01/23/2025 (MT Newswires) -- Tiziana Life Sciences ( TLSA ) said Thursday it does not intend to embark on any capital raising activity "for the immediate future."

The company said the decision comes after the news that came out on Wednesday about the discovery of new immune biomarkers in patients with non-active secondary progressive multiple sclerosis treated with nasal foralumab.

Tiziana said it continues to be committed to delivering shareholder value and advancing its drug candidates via clinical trials and regulatory processes.

Tiziana shares fell 10% in recent trading.

Price: 0.72, Change: -0.08, Percent Change: -10.01